TrialPanorama/TrialPanorama-database huggingface dataset:
Study NCT03142646 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT04168619 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT01342666 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study NCT01847248 — Predictive Biomarker (PRD): HSPA12B mRNA
Genes: HSPA12B; C20orf60
Study NCT00241930 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT01863004 — Predictive Biomarker (PRD): DYSF mRNA
Genes: DYSF; FER1L1
Study NCT02715063 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01138722 — Predictive Biomarker (PRD): GCNT2 mRNA
Genes: GCNT2; GCNT5; II; NACGT1
Study NCT03372616 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03626233 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT03626233 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Placenta growth factor
Genes: PGF; PGFL; PLGF
Study NCT02093533 — Pharmacodynamic Biomarker (PDY): Complement C5
Genes: C5; CPAMD4
Study NCT02454244 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT02454244 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04293614 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04306926 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT00220090 — Predictive Biomarker (PRD): CCK mRNA
Genes: CCK
Study NCT03094052 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04388826 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT00001934 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT02437318 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02437318 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT02437318 — Predictive Biomarker (PRD): PIK3CA mRNA
Genes: PIK3CA
Study NCT02437318 — Predictive Biomarker (PRD): Hormone receptor
Study NCT03851705 — Predictive Biomarker (PRD): PCSK9 mRNA
Genes: PCSK9; NARC1; PSEC0052
Study NCT03851705 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT01066845 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT01066845 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00641381 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT04180267 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT03243461 — Pharmacodynamic Biomarker (PDY): Valproic acid
Study NCT03781063 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT03979651 — Predictive Biomarker (PRD): NRAS mRNA
Genes: NRAS; HRAS1
Study NCT04782921 — Surrogate Endpoint (SUR): Probing pocket depth
Study NCT00136721 — Predictive Biomarker (PRD): PINK1 mRNA
Genes: PINK1
Study NCT00136721 — Pharmacodynamic Biomarker (PDY): Leucine-rich repeat kinase 2
Genes: LRRK2; PARK8
Study NCT01086527 — Predictive Biomarker (PRD): SLCO2B1 mRNA
Genes: SLCO2B1; KIAA0880; OATP2B1; OATPB; SLC21A9
Study NCT00883597 — Predictive Biomarker (PRD): APC mRNA
Genes: APC; DP2.5
Study NCT01486732 — Predictive Biomarker (PRD): FLT1 mRNA
Genes: FLT1; FLT; FRT; VEGFR1
Study NCT03459222 — Predictive Biomarker (PRD): Indoleamine 2,3-dioxygenase 1
Genes: IDO1; IDO; INDO
Study NCT02144935 — Predictive Biomarker (PRD): AFM mRNA
Genes: AFM; ALB2; ALBA
Study NCT03308487 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study NCT03308487 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT03308487 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study NCT04810884 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT03132142 — Predictive Biomarker (PRD): TPRA1 mRNA
Genes: TPRA1; GPR175; TMEM227; PP6566
Study NCT03132142 — Predictive Biomarker (PRD): TRPV1 mRNA
Genes: TRPV1; VR1
Study NCT00788112 — Predictive Biomarker (PRD): HDAC1 mRNA
Genes: HDAC1; RPD3L1
Study NCT00788112 — Predictive Biomarker (PRD): HDAC6 mRNA
Genes: HDAC6; KIAA0901; JM21
Study NCT00799565 — Predictive Biomarker (PRD): MVP mRNA
Genes: MVP; LRP
Study NCT00529048 — Pharmacodynamic Biomarker (PDY): Gastric inhibitory polypeptide
Genes: GIP
Study NCT00902044 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT00902044 — Predictive Biomarker (PRD): CD28 mRNA
Genes: CD28
Study NCT03971747 — Predictive Biomarker (PRD): AFP mRNA
Genes: AFP; HPAFP
Study NCT03492632 — Predictive Biomarker (PRD): AMH mRNA
Genes: AMH; MIF
Study NCT02936752 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT01192256 — Surrogate Endpoint (SUR): Exhaled carbon monoxide
Study NCT02573493 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study NCT02573493 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT02573493 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT00185341 — Predictive Biomarker (PRD): CCR1 mRNA
Genes: CCR1; CMKBR1; CMKR1; SCYAR1
Study NCT02709343 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT01316666 — Predictive Biomarker (PRD): NE
Study NCT02503722 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT01236989 — Predictive Biomarker (PRD): AR mRNA
Genes: AR; DHTR; NR3C4
Study NCT04226469 — Monitoring Biomarker (MOI): Matrix metalloproteinase 1
Genes: MMP1; CLG
Study NCT04116684 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04450732 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT01787994 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT00049543 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT02296125 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT00159016 — Predictive Biomarker (PRD): PDGFRB mRNA
Genes: PDGFRB; PDGFR; PDGFR1
Study NCT01435161 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03775447 — Pharmacodynamic Biomarker (PDY): Leucine-rich repeat kinase 2
Genes: LRRK2; PARK8
Study NCT02313844 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT02280655 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04075708 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00746811 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT05374616 — Predictive Biomarker (PRD): TANGO2 mRNA
Genes: TANGO2; C22orf25
Study NCT02057354 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study NCT02057354 — Safety Biomarker (SAF): BDNF
Study NCT00768131 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT01563055 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT03132467 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT03132467 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT03132467 — Predictive Biomarker (PRD): Hormone receptor
Study NCT02912949 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02912949 — Predictive Biomarker (PRD): ERBB3 mRNA
Genes: ERBB3; HER3
Study NCT02912949 — Predictive Biomarker (PRD): NRG1 mRNA
Genes: NRG1; GGF; HGL; HRGA; NDF; SMDF
Study NCT02116829 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT03369353 — Predictive Biomarker (PRD): CXADR mRNA
Genes: CXADR; CAR
Study NCT02887313 — Surrogate Endpoint (SUR): Pathological complete response
Study NCT02740270 — Predictive Biomarker (PRD): TNFRSF18 mRNA
Genes: TNFRSF18; AITR; GITR; UNQ319/PRO364
Study NCT00626041 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03447873 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT04175886 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT04008394 — Predictive Biomarker (PRD): Lymphocyte activation antigen CD30
Genes: TNFRSF8; CD30; D1S166E
Study NCT01007344 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT03227523 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT02580448 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CYP17A1 mRNA
Genes: CYP17A1; CYP17; S17AH
Study NCT03730519 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05967754 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT05967754 — Surrogate Endpoint (SUR): Serum uric acid
Study NCT03955445 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Complement C3
Genes: C3; CPAMD1
Study NCT01581424 — Predictive Biomarker (PRD): PC mRNA
Genes: PC
Study NCT04033640 — Safety Biomarker (SAF): Glucose-6-phosphate dehydrogenase
Genes: G6PD
Study NCT00683735 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study NCT01749761 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02601053 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study NCT02197858 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00569179 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT02499614 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study NCT02499614 — Predictive Biomarker (PRD): ROS1 mRNA
Genes: ROS1; MCF3; ROS
Study NCT02499614 — Predictive Biomarker (PRD): ROS1
Genes: MCF3; ROS; c-ros-1
Study NCT01318681 — Predictive Biomarker (PRD): AR mRNA
Genes: AR; DHTR; NR3C4
Study NCT00565747 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT02940548 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01459120 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04498546 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02974192 — Predictive Biomarker (PRD): CD40 mRNA
Genes: CD40; TNFRSF5
Study NCT04768244 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT04089410 — Safety Biomarker (SAF): BDNF
Study NCT01636284 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT01862003 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT01862003 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT01862003 — Predictive Biomarker (PRD): ERBB3 mRNA
Genes: ERBB3; HER3
Study NCT04023019 — Predictive Biomarker (PRD): Coagulation factor VIII
Genes: F8; F8C
Study NCT02867137 — Predictive Biomarker (PRD): S100B mRNA
Genes: S100B
Study NCT02867137 — Predictive Biomarker (PRD): GFAP mRNA
Genes: GFAP
Study NCT02183584 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study NCT04435158 — Pharmacodynamic Biomarker (PDY): Antidrug antibody
Study NCT04435158 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT02735200 — Surrogate Endpoint (SUR): Serum calcium
Study NCT00267176 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03093714 — Predictive Biomarker (PRD): CFTR mRNA
Genes: CFTR; ABCC7
Study NCT04069988 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03265184 — Predictive Biomarker (PRD): CGA mRNA
Genes: CGA
Study NCT03692520 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT03744390 — Predictive Biomarker (PRD): IDH2 mRNA
Genes: IDH2
Study NCT00152438 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03620396 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Trefoil factor 3
Genes: TFF3; ITF; TFI
Study NCT04630483 — Safety Biomarker (SAF): Neutrophil to lymphocyte
Study NCT04630483 — Safety Biomarker (SAF): Platelet to lymphocyte
Study NCT00175279 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT02752542 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04962854 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT03557190 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT03557190 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Endothelin-1
Genes: EDN1
Study NCT03497377 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT01642888 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT03606577 — Surrogate Endpoint (SUR): Minimal residual disease response rate
Study NCT02229617 — Surrogate Endpoint (SUR): Serum testosterone
Study NCT00344162 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03379974 — Safety Biomarker (SAF): von Willebrand factor
Genes: VWF; F8VWF
Study NCT02418091 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02482233 — Surrogate Endpoint (SUR): Exhaled carbon monoxide
Study NCT06037135 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01069549 — Predictive Biomarker (PRD): AGTR1 mRNA
Genes: AGTR1; AGTR1A; AGTR1B; AT2R1; AT2R1B
Study NCT01069549 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT01069549 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): Angiotensinogen
Genes: AGT; SERPINA8
Study NCT02862093 — Safety Biomarker (SAF): SLC6A3
Genes: DAT
Study NCT00095550 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04076033 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03994146 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00806585 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT01109095 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT01109095 — Predictive Biomarker (PRD): CD28 mRNA
Genes: CD28
Study NCT00637910 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT03809299 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01924780 — Predictive Biomarker (PRD): CAP1 mRNA
Genes: CAP1; CAP
Study NCT01071967 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00003604 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT03505099 — Pharmacodynamic Biomarker (PDY): Survival motor neuron protein
Genes: SMN1; SMN; SMNT;; SMN2; SMNC
Study NCT03755193 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT03563547 — Predictive Biomarker (PRD): FH mRNA
Genes: FH
Study NCT03563547 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT02341924 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study NCT02341924 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT02341924 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT02675829 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04439266 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT02898948 — Monitoring Biomarker (MOI): Procalcitonin
Study NCT04220359 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00961142 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT04520165 — Predictive Biomarker (PRD): Interleukin 5
Genes: IL5
Study NCT04520165 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT04520165 — Predictive Biomarker (PRD): TSLP mRNA
Genes: TSLP
Study NCT04520165 — Predictive Biomarker (PRD): IL5RA mRNA
Genes: IL5RA; IL5R
Study NCT03467802 — Predictive Biomarker (PRD): EMD mRNA
Genes: EMD; EDMD; STA
Study NCT03089294 — Predictive Biomarker (PRD): PDE5A mRNA
Genes: PDE5A; PDE5
Study NCT01276951 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00031733 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT00031733 — Safety Biomarker (SAF): Interleukin 12
Study NCT00646386 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT01968980 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT03147456 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study NCT03490994 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study NCT03904160 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03552770 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT03552770 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT04546789 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase BTK
Genes: BTK; AGMX1; ATK; BPK
Study NCT01897233 — Predictive Biomarker (PRD): CFTR mRNA
Genes: CFTR; ABCC7
Study NCT02594215 — Predictive Biomarker (PRD): AKT1 mRNA
Genes: AKT1; PKB; RAC
Study NCT02520778 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT02520778 — Predictive Biomarker (PRD): Apoptosis regulator Bcl-2
Genes: BCL2
Study NCT02520778 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT00697814 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT05386446 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study NCT04117451 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03313206 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT01072357 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT01072357 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT03573791 — Predictive Biomarker (PRD): TBXT mRNA
Genes: TBXT; T
Study NCT03713801 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study NCT00920686 — Predictive Biomarker (PRD): NXN mRNA
Genes: NXN; NRX
Study NCT02540421 — Surrogate Endpoint (SUR): Cervical intraepithelial neoplasia
Study NCT04231864 — Predictive Biomarker (PRD): Indoleamine 2,3-dioxygenase 1
Genes: IDO1; IDO; INDO
Study NCT03540680 — Safety Biomarker (SAF): Cyclin-dependent kinase inhibitor 1
Genes: CDKN1A
Study NCT04272801 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT01884181 — Pharmacodynamic Biomarker (PDY): Huntingtin
Genes: HTT; HD; IT15
Study NCT00457626 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01005290 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02633358 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT03943277 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT03943277 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT03650023 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02866747 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT01955694 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study NCT02876471 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00845611 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HLA-A
Study NCT00494442 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study NCT00494442 — Predictive Biomarker (PRD): BRCA2 mRNA
Genes: BRCA2; FACD; FANCD1
Study NCT00944801 — Predictive Biomarker (PRD): O-6-methylguanine-DNA-alkyltransferase
Genes: MGMT
Study NCT02429960 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01966627 — Predictive Biomarker (PRD): GCKR mRNA
Genes: GCKR
Study NCT01966627 — Predictive Biomarker (PRD): PNPLA3 mRNA
Genes: PNPLA3; ADPN; C22orf20
Study NCT04585178 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT04585178 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02538614 — Predictive Biomarker (PRD): CD37 mRNA
Genes: CD37; TSPAN26
Study NCT04354610 — Predictive Biomarker (PRD): ACE2 mRNA
Genes: ACE2; UNQ868/PRO1885
Study NCT04354610 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Neutrophil gelatinase-associated lipocalin
Genes: LCN2; HNL; NGAL
Study NCT05318950 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT01762072 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study NCT01762072 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04191226 — Predictive Biomarker (PRD): Microsatellite instability
Study NCT01190319 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03402711 — Predictive Biomarker (PRD): GCNT2 mRNA
Genes: GCNT2; GCNT5; II; NACGT1
Study NCT03402711 — Predictive Biomarker (PRD): SERPINA5 mRNA
Genes: SERPINA5; PCI; PLANH3; PROCI
Study NCT02521116 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01781988 — Predictive Biomarker (PRD): DNA excision repair protein ERCC-1
Genes: ERCC1
Study NCT01781988 — Predictive Biomarker (PRD): Ribonucleoside-diphosphate reductase large subunit
Genes: RRM1; RR1
Study NCT01781988 — Predictive Biomarker (PRD): Thymidylate synthase 
Genes: TYMS; TS; OK/SW-cl.29
Study NCT03580044 — Predictive Biomarker (PRD): MBL2 mRNA
Genes: MBL2; COLEC1; MBL
Study NCT04437576 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 8
Genes: CXCL8; IL8
Study NCT01948102 — Predictive Biomarker (PRD): IGFALS mRNA
Genes: IGFALS; ALS
Study NCT02892292 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HLA-A
Study NCT02892292 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HLA-B
Genes: AS
Study NCT02892292 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HLA-C
Genes: HLA-JY3, D6S204, PSORS1
Study NCT02892292 — Safety Biomarker (SAF): HLA-DRB1
Genes: HLA-DR1B
Study NCT02892292 — Safety Biomarker (SAF): HLA-DRB1 and HLA-DQB1
Study NCT02892292 — Safety Biomarker (SAF): HLA-DQB1
Genes: IDDM1; CELIAC1
Study NCT00098280 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT00600340 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT00600340 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT01073969 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT01073969 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT01073969 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study NCT01073969 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT04697927 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT00399529 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT00003561 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT01093014 — Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Growth/differentiation factor 8
Genes: MSTN; GDF8